GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $390,000 | +63.9% | 16,300 | 0.0% | 0.05% | +37.8% |
| Q4 2020 | $238,000 | +3.0% | 16,300 | 0.0% | 0.04% | -9.8% |
| Q3 2020 | $231,000 | -3.8% | 16,300 | 0.0% | 0.04% | -16.3% |
| Q2 2020 | $240,000 | +38.7% | 16,300 | -61.2% | 0.05% | +14.0% |
| Q1 2020 | $173,000 | – | 42,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,500,000 | $25,725,000 | 3.13% |
| CADIAN CAPITAL MANAGEMENT, LP | 3,830,399 | $28,153,000 | 1.28% |
| Mesirow Financial Investment Management, Inc. | 33,001 | $243,000 | 1.25% |
| Bellevue Group AG | 1,339,502 | $9,845,000 | 0.62% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 260,000 | $1,912,000 | 0.58% |
| Lyon Street Capital, LLC | 109,850 | $807,000 | 0.50% |
| Private Wealth Partners, LLC | 300,000 | $2,205,000 | 0.34% |
| Penn Capital Management Company, LLC | 455,064 | $3,345,000 | 0.25% |
| HighTower Advisors, LLC | 2,337,132 | $17,179,000 | 0.12% |
| Schonfeld Strategic Advisors LLC | 376,000 | $2,763,000 | 0.12% |